Pictet Asset Management Holding Sa Intra Cellular Therapies, Inc. Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
Shares
7 transactions
Others Institutions Holding ITCI
# of Institutions
71Shares Held
14.6MCall Options Held
38KPut Options Held
3.6K-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.67MShares$220 Million0.13% of portfolio
-
Morgan Stanley New York, NY1.4MShares$185 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY760KShares$100 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL625KShares$82.4 Million0.27% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...